Saturday, June 10, 2023
THE SENIOR HEALTH LETTER
No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate
The Senior Health Letter
No Result
View All Result
Home Alzheimer's

Nanotechnology could enable test for early Alzheimer’s Disease

Delmar by Delmar
March 17, 2021
in Alzheimer's
0
Nanotechnology could enable test for early Alzheimer’s Disease
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter


University of Manchester scientists have found beforehand unseen blood biomarkers which could sooner or later be used to test for Alzheimer’s illness, years earlier than its signs seem.

The ground-breaking research, printed in ACS Nano, used cutting-edge nanotechnology uniquely developed and patented by the Nanomedicine Lab in Manchester, to extract blood indicators of neurodegeneration in a mouse mannequin of Alzheimer’s illness. The research was funded by the Medical Research Council.

Tests that seize early indicators of neurodegeneration in blood supply monumental potential for Alzheimer’s illness and different dementia sufferers to obtain efficient therapy or handle successfully their progressive situation earlier than important mind harm happens.

Today, Alzheimer’s illness will be identified by imaging strategies – mind scans – and is barely doable after somebody has been exhibiting behavioural signs, corresponding to reminiscence impairment.

By the time signs emerge nonetheless, the pathology is already well-established within the mind – when it’s usually too late to deal with sufferers successfully.

Though early markers of Alzheimer’s illness are believed to be current in blood, their minute ranges make it extraordinarily tough to detect them – like trying for a needle in a haystack.

But because of the know-how developed by the Manchester crew, low blood indicators that could non-invasively describe the onset of Alzheimer’s illness can now be magnified and analysed.

Dr Marilena Hadjidemetriou, the lead researcher of the research and Lecturer in Nano-omics stated: “Hidden info in blood is more likely to echo the advanced cascade of occasions occurring within the mind of Alzheimer’s illness sufferers.

“We needed to engineer a nanotechnology blood-mining platform to be able to uncover this info and establish early indicators of Alzheimer’s illness on the pre-disease state – earlier than the onset of amyloid plaque formation within the mind.’’

Amyloid plaques are clumps of protein fragments that are poisonous to nerve cells

The crew employed nanotechnology to be able to improve the sensitivity of mass spectrometry, a proteomic method used to analyse the patterns of proteins in blood.

They used tiny nano-sized spheres, known as liposomes, as a instrument to ‘fish out’ illness particular proteins from blood.

When injected in mice with Alzheimer’s Disease, nanoparticles spontaneously picked up a whole lot of neurodegeneration-associated proteins onto their surfaces.

The nanoparticles had been then retrieved intact from blood circulation and the molecular signatures on their floor had been analysed.

');
ppLoadLater.placeholderFBSDK = ppLoadLater.placeholderFBSDK.be a part of("n");




Source link

Tags: AlzheimersDiseaseearlyenableNanotechnologytest
Advertisement Banner
Previous Post

Additional visits to senior care homes coming, B.C.’s top doctor says – Victoria News

Next Post

The Daily Herald – Two-year pilot project for assisted living for vulnerable young adults

Delmar

Delmar

Next Post
The Daily Herald – Two-year pilot project for assisted living for vulnerable young adults

The Daily Herald - Two-year pilot project for assisted living for vulnerable young adults

Discussion about this post

Recommended

Foster-care system being revamped in wake of boy’s death in Barrie home

70+ can pre-register for COVID-19 vaccinations

2 years ago
April 30: ‘Wellness As We Age’ info session on the importance of nutrition

April 30: ‘Wellness As We Age’ info session on the importance of nutrition

2 years ago

Don't Miss

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

‘I’m in jail’: BPS mothers and caregivers voice concerns with district reopening plans

April 1, 2021
As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

As Loved Ones Reunite After A Year, Dementia Experts Offer These Tips

April 1, 2021

Categories

  • Alzheimer's
  • Assisted living
  • Caregivers
  • Dementia
  • Elder Care
  • Home Care
  • Mindfulness
  • Seniors advocate
  • Uncategorized
  • Wellness

Follow us

Recent News

(2021-2026) Nursing Home Beds Market Size, Demand Status | Global Industry Segment Analysis, Growing Status of Key Players

Advice You Need To Know About Personal Development

May 12, 2021
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation

Advocate Aurora Enterprises acquires national leader in home care and wellness offerings Senior Helpers

April 1, 2021
March 2021
S M T W T F S
 123456
78910111213
14151617181920
21222324252627
28293031  
    Apr »
  • About Us
  • Contact Us
  • Privacy & Policy

© 2021 The Senior health Letter

No Result
View All Result
  • Home
  • Home Care
  • Elder Care
  • Wellness
  • Dementia
  • Caregivers
  • Alzheimer’s
  • Assisted living
  • Mindfulness
  • Seniors advocate

© 2021 The Senior health Letter